Regulatory Approvals

Meitheal Pharmaceuticals Announces FDA Approval of Garzulys™ (insulin aspart-fsan) Injection

By

Regulatory Approvals — Meitheal Pharmaceuticals Announces FDA Approval of Garzulys™ (insulin aspart-fsan) Injection  BioSpace

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. July 31, 2026.

By

Related Post

Regulatory Approvals

FDA approves Simtriyo for treating ADHD in children and adults

Regulatory Approvals

FDA clears RadNet’s breast ultrasound AI solution

Regulatory Approvals

FDA Approves New Once-Daily Pill to Lower LDL Cholesterol

Financial News For All

Business Economy Finance

Commodities Price Update: Crude Oil $85.80, Brent $90.04, Copper $6.48, Coal $104.75 — Jul 31, 2026 11:00 AM EDT

Regulation

SEC Announces Continuation of Small Business Advisory Committee Meeting

Regulation

Administrator Zeldin Wraps Swing Through Virginia, Emphasizing Importance of Chesapeake Bay Watershed and Ensuring Key Partners Lead in Innovative Technology to Protect the Environment and Grow the Economy

Business Economy Finance

Commodities Price Update: Crude Oil $84.83, Brent $90.25, Copper $6.48, Coal $104.75 — Jul 31, 2026 8:00 AM EDT